BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-03

180 industry Phase 2/3 trial readout(s) and 33 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2026-02 | 2026-04 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-03-05Complete response lettercomplete responseRosemont Pharmaceuticals Holdings, Inc.suspensionCRL 2026-03-05: Rosemont Pharmaceuticals Holdings, Inc. NDA 220140 (oral suspension)
2026-03-05FDA approvalapprovedJANSSEN BIOTECHTECVAYLIApproved 2026-03-05: TECVAYLI (BLA761291 SUPPL18)
2026-03-06FDA approvalapprovedBRISTOL BMYSOTYKTUApproved 2026-03-06: SOTYKTU (NDA214958 SUPPL2)
2026-03-06FDA approvalapprovedPFIZER PFEXELJANZApproved 2026-03-06: XELJANZ (NDA213082 SUPPL13)
2026-03-06FDA approvalapprovedPF PRISM CVXELJANZApproved 2026-03-06: XELJANZ (NDA203214 SUPPL41)
2026-03-06FDA approvalapprovedPFIZER PFEXELJANZApproved 2026-03-06: XELJANZ XR (NDA208246 SUPPL27)
2026-03-06FDA approvalapprovedAPHELIONPYLARIFY TRUVUApproved 2026-03-06: PYLARIFY TRUVU (NDA220089 ORIG1)
2026-03-06FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2026-03-06: SKYRIZI (BLA761105 SUPPL42)
2026-03-09FDA approvalapprovedGLAXOSMITHKLINEWELLCOVORINApproved 2026-03-09: WELLCOVORIN (NDA018342 SUPPL15)
2026-03-12FDA AdComheldAdCom 2026-03-12: Vaccines and Related Biological Products Advisory Committee
2026-03-12FDA approvalapprovedNOVARTIS PHARMS CORP NVSCOSENTYXApproved 2026-03-12: COSENTYX (BLA125504 SUPPL91)
2026-03-16Complete response lettercomplete responseAldeyra Therapeutics, Inc. ALDXReproxalap OphthalmicCRL 2026-03-16: Aldeyra Therapeutics, Inc. NDA 216442 (Reproxalap Ophthalmic Solution, ©®)
2026-03-17FDA approvalapprovedJANSSEN BIOTECHICOTYDEApproved 2026-03-17: ICOTYDE (NDA220149 ORIG1)
2026-03-17FDA approvalapprovedINTERCEPTLYNAVOYApproved 2026-03-17: LYNAVOY (NDA220295 ORIG1)
2026-03-19FDA approvalapprovedDEPROCOFLAVALTAApproved 2026-03-19: FLAVALTA (NDA216564 ORIG1)
2026-03-19FDA approvalapprovedRHYTHM RYTMIMCIVREEApproved 2026-03-19: IMCIVREE (NDA213793 SUPPL9)
2026-03-19FDA approvalapprovedNOVO NVOWEGOVY WEGOVY FLEXTOUCH WEGOVY HDApproved 2026-03-19: WEGOVY; WEGOVY FLEXTOUCH; WEGOVY HD (NDA215256 SUPPL29)
2026-03-20FDA approvalapprovedBRISTOL MYERS SQUIBB BMYOPDIVOApproved 2026-03-20: OPDIVO (BLA125554 SUPPL135)
2026-03-20FDA approvalapprovedMAP77ATONCYApproved 2026-03-20: ATONCY (NDA220320 ORIG1)
2026-03-24FDA approvalapprovedDENALI THERAPEUTICS INC. DNLIAVLAYAHApproved 2026-03-24: AVLAYAH (BLA761485 ORIG1)
2026-03-25FDA approvalapprovedCORCEPT THERAP CORTLIFYORLIApproved 2026-03-25: LIFYORLI (COPACKAGED) (NDA220641 ORIG1)
2026-03-26FDA approvalapprovedNOVO NORDISK INC NVOAWIQLI FLEXTOUCHApproved 2026-03-26: AWIQLI FLEXTOUCH (BLA761326 ORIG2)
2026-03-26FDA approvalapprovedARS PHARMS OPERATIONNEFFYApproved 2026-03-26: NEFFY (NDA214697 SUPPL2)
2026-03-27FDA approvalapprovedVERTEX PHARMS INC VERXTRIKAFTAApproved 2026-03-27: TRIKAFTA (COPACKAGED) (NDA212273 SUPPL14)
2026-03-27FDA approvalapprovedVERTEX PHARMS INC VERXALYFTREKApproved 2026-03-27: ALYFTREK (NDA218730 SUPPL1)
2026-03-27FDA approvalapprovedBIOGEN BIIBSPINRAZAApproved 2026-03-27: SPINRAZA (NDA209531 SUPPL16)
2026-03-27FDA approvalapprovedACADIA PHARMS INC ACADDAYBUEApproved 2026-03-27: DAYBUE (NDA217026 SUPPL8)
2026-03-27FDA approvalapprovedGENMAB US, INC. GMABEPKINLYApproved 2026-03-27: EPKINLY (BLA761324 SUPPL10)
2026-03-27FDA approvalapprovedTEVA PHARMACEUTICALS, INC. TEVAPONLIMSIApproved 2026-03-27: PONLIMSI (BLA761385 ORIG1)
2026-03-27FDA approvalapprovedIBSA INST BIOLICARTApproved 2026-03-27: LICART (NDA206976 SUPPL18)
2026-03-27FDA approvalapprovedVERTEX PHARMS INC VERXTRIKAFTAApproved 2026-03-27: TRIKAFTA (COPACKAGED) (NDA217660 SUPPL8)
2026-03-30FDA approvalapprovedBAXTER HLTHCARE CORP BAXEPINEPHRINEApproved 2026-03-30: EPINEPHRINE (NDA220626 ORIG1)
2026-03-30FDA approvalapprovedINCYTE CORP INCYZYNYZApproved 2026-03-30: ZYNYZ (BLA761334 SUPPL8)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-03 est.P2Epitopoietic Research CorporationNCT01903330 ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma MultiformeGlioblastoma; Gliosarcomaunknown84
2026-03P2Cumberland Pharmaceuticals CPIXNCT02682511 Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionScleroderma, Diffuse; Scleroderma, Systemic; Scleroderma, Limited; Sclerosis, Progressive Systemic; active not recruiting34
2026-03 est.P3Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdNCT04357522 Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy VolunteersPneumonia, Pneumococcalunknown1950
2026-03 est.P1/P2PT. Prodia Stem Cell IndonesiaNCT05008588 Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke InfarctIschemic Strokeactive not recruiting15
2026-03 est.P1/P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT05416749 A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid TumorsSolid Tumorssuspended216
2026-03 est.P2Kira Pharmacenticals (US), LLC.NCT05504187 Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus ErythematosusSystemic Lupus Erythematosuswithdrawn
2026-03 est.P3Binhui Biopharmaceutical Co., Ltd.NCT05868707 OH2 Injection in MelanomaMelanomarecruiting340
2026-03 est.P1/P2Forward Pharmaceuticals Co., Ltd. FWRDNCT06064812 A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.Metastatic Breast Cancer; Locally Advanced Breast Cancer; Breast Cancer Stage IV; ER+/HER2- Breast Crecruiting99
2026-03 est.P1/P2Hansoh BioMedical R&D CompanyNCT06144723 Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.Advanced Solid Tumornot yet recruiting402
2026-03 est.P1/P2Hinova Pharmaceuticals Inc.NCT06155084 A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC PatientsMetastatic Castration-resistant Prostate Cancerrecruiting84
2026-03 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06198764 A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for InjectionMental Health Issueunknown80
2026-03 est.P2Alethia BiotherapeuticsNCT06225843 Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver MetastasisMetastatic Colorectal Cancerrecruiting17
2026-03 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06239298 A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid TumorSolid Tumorunknown130
2026-03 est.P2SpinogenixNCT06442462 Study of SPG302 in Adults With SchizophreniaSchizophreniaactive not recruiting32
2026-03 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06566586 A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell LymphomaB-cell Lymphomarecruiting80
2026-03 est.P2AmacaThera Inc.NCT06709612 Postsurgical Analgesia After Hernia RepairHernia Repair; Hernia Inguinal; Hernia Surgery; Hernia, Inguinal/Surgery; Hernia, Inguinalwithdrawn
2026-03 est.P2nephCentricNCT06798675 Phase 2a Study for PK/PD of nC-001CHRONIC HYPONATREMIAnot yet recruiting24
2026-03 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT06825494 Clinical Studies for the Treatment of Advanced Solid TumorsAdvanced Solid Tumorrecruiting194
2026-03 est.P3Chiesi Farmaceutici S.p.A.NCT06917690 A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaEpidermolysis Bullosa; Junctional Epidermolysis Bullosa; Epidermolysis Bullosa, Dystrophic; Epidermorecruiting6
2026-03 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT06918743 To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II StudyPsoriatic Subjectsnot yet recruiting147
2026-03 est.P3Xiamen Amoytop Biotech Co., Ltd.NCT06927310 The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short StatureIdiopathic Short Staturerecruiting300
2026-03 est.P2BiomX LtdNCT06998043 Study With Phage for CF Subjects With Pseudomonas Lung InfectionChronic Pseudomonas Aeruginosa Infection; Cystic Fibrosis (CF)recruiting63
2026-03 est.P3Changchun BCHT Biotechnology Co.NCT07133802 Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-VaccinatPrevention of Influenzanot yet recruiting6680
2026-03 est.P3Aresus Pharma GmbHNCT07137819 Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic KeratosisActinic Keratosis of Face and Scalprecruiting280
2026-03 est.P3Mather's Pharm. Co., Ltd.NCT07181148 A Study to Evaluate the Safety and Effectiveness of MSP01-T for Bowel Cleansing Before a ColonoscopyColonoscopy; Bowel Preparationnot yet recruiting214
2026-03 est.P2Guangzhou Patronus Biotech Co., Ltd.NCT07208461 A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderRespiratory Syncytial Virus Infection Preventionactive not recruiting700
2026-03 est.P1/P2Nasus Pharma NSRXNCT07228325 Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic RhinitisAnaphylaxis; Allergyenrolling by invitation50
2026-03 est.P2Aspargo Labs, IncNCT07231185 Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile DysfunctionErectile Dysfunctionnot yet recruiting200
2026-03 est.P2Anhui Palo Alto Pharmaceuticals, Inc.NCT07324707 Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial AsthmaBronchial Asthmarecruiting30
2026-03 est.P2Next Life SciencesNCT07393334 Effects of NLS-133, a Potential Non-Hormonal "On-Demand" Male ContraceptiveMale Contraception; Semen Volume; Sperm Motilityrecruiting10
2026-03-01P2CellSight Technologies, Inc.NCT04260256 A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid TumorsCorrelate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefitterminated9
2026-03-01 est.P2Replimune, Inc. REPLNCT05743270 Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHNSquamous Cell Carcinoma of Head and Neck; Locally Advanced Head and Neck Squamous Cell Carcinoma; Rewithdrawn
2026-03-01 est.P2TRYP TherapeuticsNCT06206265 Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)Irritable Bowel Syndromeactive not recruiting14
2026-03-01 est.P1/P2SUNHO(China)BioPharmaceutical CO., Ltd.NCT06223841 A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsAdvanced Malignant Tumorsrecruiting50
2026-03-01 est.P2Innovent Biologics (Suzhou) Co. Ltd.NCT06281678 A Study of IBI363 in Subjects with Advanced Solid MalignanciesMelanoma; Non-small Cell Lung Cancer; Colorectal Cancer; Renal Cell Cancerrecruiting178
2026-03-01 est.P1/P2Nuwacell Biotechnologies Co., Ltd.NCT06825169 A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung DiseaseInterstitial Lung Disease (ILD)not yet recruiting30
2026-03-01 est.P2TNF Pharmaceuticals, Inc.NCT06942182 Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone FracturesSarcopenia in Elderly; Frailty; Frailty/Sarcopenia; Frailty in Older Adultsnot yet recruiting60
2026-03-01 est.P1/P2U: The Mind CompanyNCT07182058 Virtual tES Device Treatment for Parkinson's Disease Motor SymptomsPARKINSON DISEASE (Disorder)recruiting30
2026-03-02P3Zeria PharmaceuticalNCT04526119 A Phase III Trial of Z-338 in Paediatric Patients With Functional DyspepsiaFunctional Dyspepsiacompleted55
2026-03-02P3Sanofi SNYNCT04910776 Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase AlfaGlycogen Storage Disease Type IIactive not recruiting17
2026-03-02P3AstraZeneca AZNNCT04960709 Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer InMuscle Invasive Bladder Canceractive not recruiting712
2026-03-02 est.P1/P2Gracell Biotechnologies (Shanghai) Co., Ltd.NCT06235229 A Study of GC012F in Patients With Relapsed/Refractory Multiple MyelomaMultiple Myelomarecruiting110
2026-03-02P3Sanofi SNYNCT06805513 Actual Use Trial of Tadalafil 5 mgErectile Dysfunctioncompleted2212
2026-03-03P2Incyte Corporation INCYNCT02723994 A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaLeukemiacompleted171
2026-03-03P3Akero Therapeutics, IncNCT06161571 A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (NASH/MASH; NAFLD/MASLDactive not recruiting700
2026-03-03P2Genentech, Inc.NCT06602453 A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKEAcute Kidney Injuryterminated67
2026-03-03 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT06790862 A Trial of SHR0302Base in Patients With VitiligoVitiligoactive not recruiting155
2026-03-04P3Eli Lilly and Company LLYNCT03519945 A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)Ulcerative Colitisactive not recruiting1058
2026-03-04 est.P3AstraZeneca AZNNCT05348577 Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)Prostate Canceractive not recruiting1035
2026-03-04P3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05861128 Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)Ankylosing Spondylitiscompleted207
2026-03-04P2Hoffmann-La RocheNCT06128564 A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular DystropDuchenne Muscular Dystrophyactive not recruiting13
2026-03-04P3Novo Nordisk A/S NVONCT06221969 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin WithType 2 Diabetescompleted1024
2026-03-04P2Gilead Sciences GILDNCT06290934 Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative ColitisUlcerative Colitisactive not recruiting228
2026-03-04P3Viridian Therapeutics, Inc. VRDNNCT06625398 An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)Thyroid Eye Diseaseactive not recruiting204
2026-03-05P2AltruBio Inc.NCT06109441 Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to BiologicsUlcerative Colitisactive not recruiting50
2026-03-05P2/P3Merck Sharp & Dohme LLC MRKNCT06295809 A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)Carcinoma, Squamous Cell; Skin Neoplasmsterminated46
2026-03-05P2SkinJect, Inc.NCT06608238 Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.Nodular Basal Cell Carcinomacompleted90
2026-03-06P1/P2Hemerion TherapeuticsNCT05736406 A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of GlioblastomaPrimary Glioblastomaactive not recruiting12
2026-03-06P1/P2Carrick Therapeutics LimitedNCT05963997 A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast CancerMetastatic Breast Cancer; Locally Advanced Breast Cancer; Breast Cancercompleted49
2026-03-06P3AstraZeneca AZNNCT06040086 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsChronic Obstructive Pulmonary Disease (COPD)completed1454
2026-03-06P2Elixiron Immunotherapeutics Inc.NCT06745583 A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsMild, Moderate, or Severe Alzheimer's Diseasecompleted7
2026-03-07P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06738979 A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsObesitycompleted408
2026-03-09P1/P2Aprea Therapeutics APRENCT04905914 Study Of ATRN-119 In Patients With Advanced Solid TumorsAdvanced Solid Tumorcompleted43
2026-03-09P2Biogen BIIBNCT05348785 A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30Parkinson Diseasecompleted650
2026-03-09P2Novo Nordisk A/S NVONCT05725902 Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseSickle Cell Diseasecompleted12
2026-03-09P2Shanghai Mabgeek Biotech.Co.LtdNCT07103174 A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic DermatitisAtopic Dermatitis (AD)completed60
2026-03-09P2Suzhou Abogen Biosciences Co., Ltd.NCT07285278 Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or AboveVaricella-zoster Virusactive not recruiting300
2026-03-10P3Amgen AMGNNCT03937154 Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerChemotherapy-induced Thrombocytopeniaactive not recruiting145
2026-03-10P2MapLight Therapeutics MPLTNCT05081245 ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)Autism Spectrum Disordercompleted168
2026-03-10P1/P2ALK-Abelló A/SNCT05440643 Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut AllergyPeanut Allergycompleted209
2026-03-10P3Incepta Pharmaceuticals LtdNCT06305416 A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular EdemaDiabetic Macular Edema; Diabetic Retinopathy; Macular Edema; Macular Degeneration; Retinal Disease; completed70
2026-03-10P3Samsung Bioepis Co., Ltd.NCT06348199 A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Non-small Cell Lung Cancer Stage IVactive not recruiting555
2026-03-10 est.P1/P2Bio-Thera SolutionsNCT06545617 A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian CancerPlatinum-resistant Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancerwithdrawn
2026-03-11P3argenx ARGXNCT04225156 A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).Primary Immune Thrombocytopeniacompleted101
2026-03-11P2Biogen BIIBNCT05399888 A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due toMild Cognitive Impairment Due to Alzheimer's Disease; Alzheimer's Disease Dementiaactive not recruiting416
2026-03-11P3Alzheon Inc.NCT06304883 Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD SubjectsEarly Alzheimer's Diseaseterminated163
2026-03-11P2AbViro LLCNCT06799741 A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) InfectionDENV-3 Controlled Human Infection Modelcompleted85
2026-03-11P2EIP Pharma IncNCT06815965 A Clinical Study of Neflamapimod in Patients With Dementia With Lewy BodiesDementia With Lewy Bodies (DLB)completed26
2026-03-12P3Regeneron Pharmaceuticals REGNNCT05352672 Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Melanomaactive not recruiting1546
2026-03-12P1/P2BioNTech SE BNTXNCT05547464 Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated VolunteersTuberculosisactive not recruiting497
2026-03-12P3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05676242 A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic DermatitisAtopic Dermatitiscompleted207
2026-03-12P2Merck Sharp & Dohme LLC MRKNCT06036836 Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)Solid Tumor; Cutaneous Squamous Cell Carcinoma; Endometrial Cancercompleted163
2026-03-12P2/P3Biohaven Therapeutics Ltd. BHVNNCT06425159 A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresGeneralized Epilepsyterminated27
2026-03-12P3Merck Sharp & Dohme LLC MRKNCT06698042 A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)Lung Cancer; Non-Small Cell Lung Canceractive not recruiting67
2026-03-13P2Synairgen Research Ltd.NCT06999603 Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral InfectionViral Pneumoniaterminated11
2026-03-14P2JemincareNCT06949020 A Dose-finding Study of JMKX003142 in Treatment of Cardiac EdemaCardiac Edemacompleted160
2026-03-15 est.P3Vera Therapeutics, Inc. VERANCT05609812 Atacicept in Subjects With Active Lupus Nephritis (COMPASS)Lupus Nephritis (LN)withdrawn
2026-03-15P1/P2Enlivex Therapeutics Ltd. ENLVNCT06233474 Study of Intra-articular Allocetra in Knee OsteoarthritisOsteoarthritis, Kneecompleted134
2026-03-16 est.P3AstraZeneca AZNNCT03997123 Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCTriple Negative Breast Neoplasmsactive not recruiting923
2026-03-16P2Vir Biotechnology, Inc. VIRNCT04856085 Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionHepatitis B, Chroniccompleted244
2026-03-16P3Eli Lilly and Company LLYNCT05803421 A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased CardioType 2 Diabetes; Obesity; Overweight or Obesity; Overweight; Cardiovascular Diseases; Chronic Kidneycompleted2749
2026-03-16P2Aptarion Biotech AGNCT05962606 Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.Community-acquired Pneumoniacompleted150
2026-03-16P3SandozNCT06159790 A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-smMetastatic NSCLCcompleted218
2026-03-16P2/P3Gilead Sciences GILDNCT06613685 Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been TreatedHIV-1-infectionterminated73
2026-03-16 est.P3Baxis Pharmaceuticals, Inc.NCT06911424 Efficacy of Fusidic Acid 1% in the Treatment of Bacterial ConjunctivitisBacterial Conjunctivitisrecruiting400
2026-03-17P2Agios Pharmaceuticals, Inc. AGIONCT05490446 A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)Myelodysplastic Syndromesactive not recruiting87
2026-03-17P2Cynata Therapeutics LimitedNCT05643638 A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHDGraft Versus Host Disease, Acuteterminated65
2026-03-17P3Incyte Corporation INCYNCT06113471 A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)NonSegmental Vitiligoactive not recruiting450
2026-03-17P2Celldex Therapeutics CLDXNCT06366750 A Study of Barzolvolimab in Patients With Prurigo NodularisPrurigo Nodularisactive not recruiting140
2026-03-17P3BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.NCT06704581 A Study of BGM0504 Injection in Participants With Obesity or OverweightOverweight or Obesitycompleted652
2026-03-18P1/P2Avidity Biosciences, Inc.NCT05747924 Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)FSHD; FSHD1; FSHD2; FMD; FMD2; Fascioscapulohumeral Muscular Dystrophy; Fascioscapulohumeral Musculacompleted90
2026-03-18P2Eisai Inc.NCT06188559 A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic BreasBreast Cancercompleted56
2026-03-18P2Biohaven Therapeutics Ltd. BHVNNCT06423781 Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)Major Depressive Disordercompleted233
2026-03-18 est.P2Shanghai Bao Pharmaceuticals Co., Ltd.NCT07025408 Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree BurnsBurn; Burn Wounds - Partial Thickness (2nd Degree)recruiting144
2026-03-19P1/P2Seagen, a wholly owned subsidiary of PfizerNCT03786081 Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical CancerCervical Cancerterminated214
2026-03-19P2/P3CSL BehringNCT03805789 The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell TransplantAcute-graft-versus-host Diseaseterminated222
2026-03-19P2Novartis Pharmaceuticals NVSNCT05268289 Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VLupus Nephritisterminated81
2026-03-19 est.P3Hoffmann-La RocheNCT05494619 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)Guillain-Barré Syndromewithdrawn
2026-03-19P3Astellas Pharma IncNCT06206421 A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through MenopauseHot Flashescompleted277
2026-03-19 est.P3Gan & Lee Pharmaceuticals.NCT06767761 A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial InsulinDiabetesactive not recruiting580
2026-03-19P1/P2Shandong Suncadia Medicine Co., Ltd.NCT06780267 Clinical Study of HRS-2129 for Postoperative Analgesia in OrthopaedicsPostoperative Pain in Orthopaedicscompleted199
2026-03-19P2Eli Lilly and Company LLYNCT06817356 A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderAlcohol Use Disordercompleted308
2026-03-19P2Engrail Therapeutics INCNCT07193563 A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety DisorderSocial Anxiety Disorder (SAD)completed47
2026-03-20P2Seagen, a wholly owned subsidiary of PfizerNCT03485209 Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsColorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Exocrine Pancreatic Cancer; Carcinoma, Squamouactive not recruiting350
2026-03-20P3Jiangsu HengRui Medicine Co., Ltd.NCT05814354 SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical TrialBreast Canceractive not recruiting551
2026-03-20P2Bioxodes S.A.NCT05970224 A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous IntracerebralIntracerebral Hemorrhagecompleted23
2026-03-20P3Arthrosi TherapeuticsNCT06439602 Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)Gout; Arthritis, Gouty; Hyperuricemia; Gout Chroniccompleted818
2026-03-21P2/P3REDNVIA Co., Ltd.NCT05143177 A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)Calcific Aortic Valve Diseaseterminated486
2026-03-21P2Shanghai Minwei Biotechnology Co., LtdNCT07791654 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants WOverweight , Obesitycompleted120
2026-03-21P2Shanghai Minwei Biotechnology Co., LtdNCT07804810 Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityOverweight , Obesitycompleted120
2026-03-22 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT06637254 A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial AsthmaBronchial Asthmaunknown219
2026-03-23P2Caliway Biopharmaceuticals Co., Ltd.NCT06303570 A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease LipomasDercum's Diseasecompleted19
2026-03-23P3LuciLabNCT06748625 Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia PreventionRisk Behavior; Cognitive Declinecompleted368
2026-03-23P2Corxel PharmaceuticalsNCT07011797 A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese ParticipantsObesitycompleted250
2026-03-24P3Abnoba GmbhNCT02106572 Therapeutic Instillation of MistletoeSuperficial Bladder Cancerterminated174
2026-03-24P1/P2BriaCell Therapeutics Corporation BCTXNCT03328026 Combination Study of SV-BR-1-GM With RetifanlimabBreast Cancer; Breast Neoplasm; Metastatic Breast Cancer; Breast Cancer Metastaticcompleted36
2026-03-24P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT06727058 Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and OlderInfluenza Immunizationcompleted276
2026-03-25P1/P2Kite, A Gilead CompanyNCT02625480 Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia; Relapsed/Refractory B-Cell Non-Hodgkincompleted95
2026-03-25P3Ionis Pharmaceuticals, Inc. IONSNCT04136171 CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants WiTransthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)completed1438
2026-03-25P3Novartis Pharmaceuticals NVSNCT04926818 Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisMultiple Sclerosis (MS)active not recruiting129
2026-03-25P1/P2Genmab GMABNCT05180474 GEN1047 for Solid Tumors - First in Human (FIH) TrialBreast Cancer, Breast Neoplasms; Endometrial Cancer, Endometrial Neoplasm; Ovarian Cancer, Ovarian Nterminated179
2026-03-25P3Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT05304767 An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaSchizophreniacompleted290
2026-03-25P3Novartis Pharmaceuticals NVSNCT06267560 Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDElevated Lp(a) and Established Atherosclerotic Cardiovascular Diseasecompleted422
2026-03-25P3AvadelNCT06525077 Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)Idiopathic Hypersomniacompleted157
2026-03-25P1/P2EyeBiotech Ltd.NCT06664502 A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-findinDiabetic Macular Edema (DME); Neovascular Age-related Macular Degeneration (NVAMD); BRVO - Branch Recompleted38
2026-03-25P1/P2Capsida Biotherapeutics, Inc.NCT06983158 A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) EncephalopathyDevelopmental and Epileptic Encephalopathyterminated1
2026-03-25P2Oruka Therapeutics, Inc. ORKANCT07090330 ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisPlaque Psoriasisactive not recruiting80
2026-03-26P1/P2Ascletis Pharma (China) Co., LimitedNCT06679959 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With ObesityChronic Weight Managementcompleted115
2026-03-26P3Gan & Lee Pharmaceuticals.NCT06728124 A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight SubjectsObesity/Overweightcompleted640
2026-03-26P2Janssen Research & Development, LLCNCT06881251 A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)Dermatitis, Atopicterminated256
2026-03-27P2Clementia Pharmaceuticals Inc.NCT05039515 A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FFibrodysplasia Ossificans Progressivaterminated113
2026-03-27P2Seagen, a wholly owned subsidiary of PfizerNCT06003231 A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Endometrial Neoplasms; Head and Neck Neoplasmsactive not recruiting120
2026-03-27P2Regeneron Pharmaceuticals REGNNCT06299111 A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central CatheVenous Thromboembolismcompleted195
2026-03-27P3ModernaTX, Inc.NCT07117487 A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of AgeRespiratory Syncytial Viruscompleted507
2026-03-28 est.P3CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT06543966 Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and VomitingPost-operative Nausea and Vomiting (PONV)unknown486
2026-03-28 est.P3Lunan Better Pharmaceutical Co., LTD.NCT06879782 Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye DiseaseDry Eye Disease (DED)recruiting820
2026-03-29P3MAXVAX Biotechnology Limited Liability CompanyNCT06447779 Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and OlderHerpes Zosteractive not recruiting25000
2026-03-30 est.P2Apollomics Inc. APLMNCT03175224 APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsSolid Tumors; Advanced Cancer; Renal Cancer; Gastric Cancer; Gastroesophageal Junction Adenocarcinomrecruiting497
2026-03-30P1/P2Takeda TAKNCT04420884 A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsSolid Neoplasmscompleted248
2026-03-30 est.P1/P2Criterium, Inc.NCT05230810 Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.HER2-positive Metastatic Breast Canceractive not recruiting40
2026-03-30P3Incyte Corporation INCYNCT05429268 Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphomaactive not recruiting82
2026-03-30 est.P2Artcline GmbHNCT05442710 Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal TherapySepsis, Severerecruiting142
2026-03-30P3AstraZeneca AZNNCT05883644 Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)Advanced Hepatocellular Carcinomaactive not recruiting111
2026-03-30P1/P2Agyany Pharma LTDNCT06193421 High-Dose Ambroxol in GBA1-Related ParkinsonParkinson Disease; GBA Gene Mutationterminated46
2026-03-30P1/P2Genmab GMABNCT06685068 A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid TumorsAdvanced Solid Tumorterminated23
2026-03-30 est.P3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06771245 A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsMild-to-moderate Essential Hypertensionnot yet recruiting606
2026-03-30P2PRG Science & Technology Co., Ltd.NCT06775041 Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPHutchinson-Gilford Progeria Syndromecompleted10
2026-03-30P3Vanda Pharmaceuticals VNDANCT06836557 Open Label Safety Study of Tradipitant in Idiopathic and Diabetic GastroparesisIdiopathic Gastroparesis; Diabetic Gastroparesis; Gastroparesiscompleted17
2026-03-30 est.P2Guangzhou JOYO Pharma Co., LtdNCT06895031 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASSolid Tumor; Pancreatic Ductal Adenocarcinoma (PDAC); Non-small Cell Lung Cancer (NSCLC); Colorectalrecruiting210
2026-03-30P3HAL AllergyNCT06920771 A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy inHouse Dust Mite Allergy; House Dust Mite Rhinitiscompleted691
2026-03-30 est.P2Guangzhou Novaken Pharm Co., Ltd.NCT07156773 The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off EpisodesParkinson Diseaserecruiting84
2026-03-30 est.P2Guangzhou Novaken Pharm Co., Ltd.NCT07168720 The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in ChildrenPreoperative Sedationrecruiting64
2026-03-31P3Optinose US Inc.NCT03747458 OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal PolypsBilateral Nasal Polyposiscompleted40
2026-03-31P3ADC Therapeutics S.A. ADCTNCT04384484 Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphomaactive not recruiting440
2026-03-31 est.P3Addpharma Inc.NCT05400317 A Study to Evaluate the Efficacy and Safety of AD-218Mixed Dyslipidemiarecruiting520
2026-03-31 est.P2Ever Neuro Pharma GmbHNCT05755997 CERebrolysin In CADASILCadasilactive not recruiting30
2026-03-31P2Biotheus Inc.NCT05918107 A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPMMPMcompleted31
2026-03-31 est.P2Changchun GeneScience Pharmaceutical Co., Ltd.NCT06189495 A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Systemic Sclerosis Associated Interstitial Lung Disease; Rheumatoid Arthritis Associated Interstitiarecruiting30
2026-03-31 est.P1/P2Novatim Immune Therapeutics (Zhejiang) Co., Ltd.NCT06223646 A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple MyelomaMultiple Myelomaunknown29
2026-03-31 est.P1/P2Delta-Fly Pharma, Inc.NCT06382168 DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaLeukemia, Myeloid, Acuteunknown39
2026-03-31 est.P1/P2Chengdu Origen Biotechnology Co., Ltd.NCT06458595 Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Age-related Macular Degenerationrecruiting44
2026-03-31 est.P3Green Cross WellbeingNCT06493799 In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the EChronic Liver Diseaserecruiting226
2026-03-31 est.P3Chong Kun Dang PharmaceuticalNCT06643819 Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202AEssential Hypertensionrecruiting324
2026-03-31P2Sanofi SNYNCT06691113 A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without NasChronic Rhinosinusitis Without Nasal Polypscompleted66
2026-03-31P1/P2GuangZhou Cellgenes Biotechnology Co., Ltd.NCT06740149 Efficacy and Safety of BMSCs (CG-BM1) for ACLF PatientsAcute-On-Chronic Liver Failurecompleted100
2026-03-31 est.P1/P2Shanghai Escugen Biotechnology Co., LtdNCT06853444 A Phase 1/2 Study of ESG206 in Patients With Primary Immune ThrombocytopeniaImmune Thrombocytopenia (ITP)recruiting84
2026-03-31 est.P3Ahn-Gook Pharmaceuticals Co.,LtdNCT07198347 Efficacy and Safety of AG2001 in Patients With Acute BronchitisAcute Bronchitisnot yet recruiting300
2026-03-31 est.P3Longbio PharmaNCT07291284 Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic RhinitisSeasonal Allergic Rhinitisactive not recruiting546
2026-03-31 est.P3NTC srlNCT07465705 Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)Elective Colonoscopyrecruiting412
2026-03-31P2Samsung Bioepis Co., Ltd.NCT07550504 A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNVAge-Related Macular Degeneration; Branch Retinal Vein Occlusion With Macular Edema; Central Retinal completed30

← 2026-02 | 2026-04 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.